% | $
Quotes you view appear here for quick access.

CTI BioPharma Corp. Message Board

  • clsnphase3 clsnphase3 Sep 12, 2012 10:06 AM Flag

    CLSN is next MDVN

    Liver, and potential use in Breast & Lung Cancer treatment.

    This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.

    Thermodox is smacking these tumors in a GOOD way. HEAT Trials/Data should show this. I think a # of Oncologists realize this is the FUTURE.

    I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.

    Do your DD ; This stock is going much higher IMHO.

1.12-0.02(-1.75%)Feb 5 4:00 PMEST